4-Methyl-2,5-methoxyphenylcyclopropylamine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
4-Methyl-2,5-methoxyphenylcyclopropylamine
DMCPA.png
DMCPA-3d-sticks.png
Names
IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)cyclopropanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
Properties
C12H17NO2
Molar mass 207.27 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
No verify (what is YesYNo ?)
Infobox references

DMCPA, or 4-methyl-2,5-methoxyphenylcyclopropylamine, is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 15–20 mg, and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals, anorexia, and psychedelic dreams. Shulgin gives it a +++ on the Shulgin Rating Scale.

Legality[edit]

United Kingdom[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

Pharmacology[edit]

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

See also[edit]

External links[edit]


  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.